Journal Home
Search for

Volume 30, Issue 4, Pages 477-481 (April 2006)


View previous. 15 of 21 View next.

The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population

Crisiane Wais Zanrossoa, Ana Hatagimab, Mariana Emerencianoa, Flávio Ramosc, Alexandre Figueiredoa, Têmis Maria Félixd, Sandra L. Segald, Roberto Giuglianid, Maria Tereza Cartaxo Munizc, Maria S. Pombo-de-OliveiraaCorresponding Author Informationemail address

Received 30 May 2005

Refers to erratum:
Erratum to “The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population” [Leuk. Res. 30 (2006) 477–481]
Crisiane Wais Zanrosso, Ana Hatagima, Mariana Emerenciano, Flávio Ramos, Alexandre Figueiredo, Têmis Maria Félix, Sandra L. Segal, Roberto Giugliani, Maria Tereza Cartaxo Muniz, Maria S. Pombo-de-Oliveira
Leukemia Research
July 2009 (Vol. 33, Issue 7, Page 1009)
Full Text | Full-Text PDF (72 KB)

Abstract 

The polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene are associated with leukemogenesis. In order to investigate the influence of two polymorphisms in the MTHFR gene, 677C>T and 1298A>C, on the risk of acute lymphoblastic leukemia (ALL) we performed a case–control study in children from different Brazilians’ regions. Genotyping of 176 ALL and 199 unselected healthy subjects was performed using PCR-RFLP assay. There was no association between the 677C>T or 1298A>C and risk of ALL in total case–control sample. However, 677T allele was linked to a decrease risk of ALL [odds ratio (OR), 0.43; 95% confidence interval (CI), 0.22–0.86], whereas the 1298A>C polymorphism presents an elevated risk factor [OR, 2.01; 95% CI, 1.01–3.99] in non-White children. Our investigation provides interesting data concerning the opposite effect of A1298C polymorphisms, particularly in the light of relatively scarce data regarding the MTHFR role in leukemia susceptibility in different populations.

a Divisão de Medicina Experimental, Centro de Pesquisa, Instituto Nacional de Câncer, Rua André Cavalcanti, 37, CEP 20231-050 Rio de Janeiro, Brazil

b Departamento de Genética, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

c Divisão de Biologia Molecular do Departamento de Biologia do ICB-UPE, Recife, Pernambuco, Brazil

d Serviço de Genética Médica, Hospital de Clínicas de Porto Alegre, Rio Grande do Sul, Brazil

Corresponding Author InformationCorresponding author. Tel.: +55 21 32331324; fax: +55 21 32331470.

PII: S0145-2126(05)00316-4

doi:10.1016/j.leukres.2005.08.008


View previous. 15 of 21 View next.